Sage Therapeutics Inc (SAGE)
13.58
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 10:58
Sage Therapeutics Price to Book Value: 1.021 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.021 |
| April 24, 2024 | 1.052 |
| April 23, 2024 | 0.9735 |
| April 22, 2024 | 0.969 |
| April 19, 2024 | 1.002 |
| April 18, 2024 | 0.9799 |
| April 17, 2024 | 0.945 |
| April 16, 2024 | 1.175 |
| April 15, 2024 | 1.152 |
| April 12, 2024 | 1.161 |
| April 11, 2024 | 1.246 |
| April 10, 2024 | 1.237 |
| April 09, 2024 | 1.242 |
| April 08, 2024 | 1.248 |
| April 05, 2024 | 1.234 |
| April 04, 2024 | 1.246 |
| April 03, 2024 | 1.289 |
| April 02, 2024 | 1.297 |
| April 01, 2024 | 1.346 |
| March 28, 2024 | 1.409 |
| March 27, 2024 | 1.431 |
| March 26, 2024 | 1.400 |
| March 25, 2024 | 1.405 |
| March 22, 2024 | 1.445 |
| March 21, 2024 | 1.501 |
| Date | Value |
|---|---|
| March 20, 2024 | 1.480 |
| March 19, 2024 | 1.449 |
| March 18, 2024 | 1.456 |
| March 15, 2024 | 1.501 |
| March 14, 2024 | 1.489 |
| March 13, 2024 | 1.549 |
| March 12, 2024 | 1.530 |
| March 11, 2024 | 1.592 |
| March 08, 2024 | 1.661 |
| March 07, 2024 | 1.606 |
| March 06, 2024 | 1.588 |
| March 05, 2024 | 1.596 |
| March 04, 2024 | 1.637 |
| March 01, 2024 | 1.643 |
| February 29, 2024 | 1.615 |
| February 28, 2024 | 1.695 |
| February 27, 2024 | 1.707 |
| February 26, 2024 | 1.701 |
| February 23, 2024 | 1.655 |
| February 22, 2024 | 1.673 |
| February 21, 2024 | 1.669 |
| February 20, 2024 | 1.667 |
| February 16, 2024 | 1.749 |
| February 15, 2024 | 1.910 |
| February 14, 2024 | 1.936 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.945
Minimum
Apr 17 2024
8.128
Maximum
Jul 12 2019
2.776
Average
2.025
Median
Price to Book Value Benchmarks
| Biogen Inc | 1.969 |
| Perspective Therapeutics Inc | 12.10 |
| Vanda Pharmaceuticals Inc | 0.4809 |
| ADMA Biologics Inc | 10.94 |
| Finch Therapeutics Group Inc | 0.1509 |
Price to Book Value Related Metrics
| PS Ratio | 9.399 |
| PEG Ratio | -1.925 |
| Price | 13.58 |
| Earnings Yield | -66.64% |
| Market Cap | 816.25M |
| PEGY Ratio | -1.925 |